Insider Trading at CVS Health Corporation?

Rdl Financial Inc acquired 11,976 shares as Cvs Health Corp (CVS)’s stock declined 4.23%. The hedge fund run by Glenn W. Welling held 2.22 million shares of the consumer services company at the end of 2016Q4, valued at $22.82 million, up from 2.08M at the end of the previous reported quarter. Cvs Health Corp Com Us$0.01 now has $84.01 billion valuation.

CVS Health Corporation (NYSE:CVS) traded down 0.7625% during trading on Friday, hitting $82.0099. Parametric Portfolio Associates LLC now owns 3,949,854 shares of the pharmacy operator’s stock valued at $317,805,000 after buying an additional 1,647,168 shares during the last quarter.

Shares of CVS Health Corporation (NYSE:CVS) opened at 79.69 on Monday. It has underperformed by 41.10% the S&P500.

1832 Asset Management Lp increased Schlumberger Ltd (NYSE:SLB) stake by 528,228 shares to 651,308 valued at $54.68M in 2016Q4. It turned negative, as 31 investors sold Herman Miller, Inc. shares while 68 reduced holdings. The Tctc Holdings Llc holds 19,525 shares with $1.54 million value, up from 7,960 last quarter. Walt Disney Co/The now has $151.86 billion valuation. Ten equity analysts rating the company a strong buy, twelve equity analysts rating the company a buy, four equity analysts rating the company a hold, zero brokers rating the stock a underperform, and finally 0 brokers rating the stock a sell with a average stock price target of $113.60. About 9.72M shares traded. (NASDAQ:MLHR) has risen 6.46% since September 15, 2016 and is uptrending. It has underperformed by 7.44% the S&P500. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and fourteen have issued a buy rating to the stock. Jefferies Group LLC’s price target indicates a potential upside of 4.07% from the company’s previous close. On Wednesday, August 5 the stock rating was maintained by RBC Capital Markets with “Outperform”. The stock has “Outperform” rating by Northland Capital on Wednesday, October 14. The firm now has a “hold” rating on the pharmacy operator’s stock. As per Friday, August 19, the company rating was downgraded by Credit Suisse. As per Friday, September 8, the company rating was maintained by Needham. The stock of Walt Disney Co (NYSE:DIS) earned “Sell” rating by Pivotal Research on Thursday, January 12. Virginia Retirement Et Al reported 336,072 shares or 0.37% of all its holdings. Next Financial Group, Inc now controls 13,343 shares with a value of $1,074,000,000. DIS’s profit will be $1.87 billion for 20.33 P/E if the $1.21 EPS becomes a reality. The pharmacy operator reported $1.71 EPS for the quarter, topping analysts’ consensus estimates of $1.67 by $0.04.

Investors sentiment decreased to 1.29 in 2016 Q4. Its up 0.17, from 0.92 in 2016Q3. It increased, as 5 investors sold JMBA shares while 17 reduced holdings. 166 funds opened positions while 593 raised stakes. (NASDAQ:MLHR). Ls Invest Ltd Llc reported 4,088 shares. First Personal Financial reported 715 shares stake. Moreover, Torch Wealth Management Limited has 2.14% invested in Walt Disney Co (NYSE:DIS). Northern Trust accumulated 145,672 shares. On Wednesday, May 3 GODRIDGE LESLIE V sold $740,539 worth of U.S. Bancorp (NYSE:USB) or 14,192 shares. Nelson Van Denburg And Campbell Wealth Mgmt Gp Limited Com holds 562 shares or 0.02% of its portfolio. Denton David M sold $18.44M worth of CVS Health Corp (NYSE:CVS) on Monday, June 12. Oakbrook Limited Liability Co reported 0.29% stake. Blair William & Il reported 0% in NiSource Inc. Numeric Limited Liability Com invested in 870,517 shares or 0.72% of the stock. Blue Edge Cap Lc invested in 3,072 shares or 0% of the stock. The Massachusetts-based Rhumbline Advisers has invested 0.01% in Herman Miller, Inc. Cincinnati has 542,000 shares.

Since March 17, 2017, it had 0 buys, and 2 sales for $20.32 million activity. They expect $1.49 earnings per share, down 9.15% or $0.15 from last year’s $1.64 per share. Boston Partners raised its position in shares of CVS Health Corporation by 48.3% in the third quarter.

Investors sentiment increased to 2.33 in Q4 2016. Its up 0.07, from 1.16 in 2016Q3. Parnassus Investments CA raised its position in shares of CVS Health Corporation by 43.4% in the third quarter. 830.51 million shares or 0.72% less from 836.58 million shares in 2016Q3 were reported. Ferguson Wellman Cap Management has 11,090 shares. Boratto Eva C had sold 6,029 shares worth $479,908 on Friday, March 17.

Since May 1, 2017, it had 1 insider buy, and 2 selling transactions for $53,717 activity. Psagot Investment House Limited invested in 49,836 shares. Nationwide Fund Advsr has invested 0.22% in CVS Health Corp (NYSE:CVS). Buckhead Cap Mgmt Ltd Liability invested in 1.38% or 92,219 shares. Compton Cap Mgmt Ri holds 1.17% or 28,328 shares in its portfolio. Boston Partners now owns 6,459,237 shares of the pharmacy operator’s stock valued at $519,711,000 after buying an additional 2,638,888 shares during the last quarter. Therefore 57% are positive. Guggenheim restated a “buy” rating on shares of CVS Health Corporation in a report on Monday, July 3rd.

More notable recent CVS Health Corp (NYSE:CVS) news were published by: Seekingalpha.com which released: “CVS Is Going Back Towards $100” on August 16, 2017, also Nasdaq.com with their article: “CVS Health Gains on Pharmacy Services, Retail Remains a Drag” published on September 13, 2017, Bizjournals.com published: “CVS Health hiring 200 in Pittsburgh” on September 08, 2017. The rating was downgraded by Morgan Stanley to “Equal-Weight” on Monday, June 20. As per Friday, January 22, the company rating was initiated by Robert W. Baird. The firm earned “Peer Perform” rating on Monday, August 14 by Wolfe Research. The rating was maintained by Oppenheimer with “Buy” on Tuesday, August 8. The stock of CVS Health Corp (NYSE:CVS) has “Overweight” rating given on Thursday, March 10 by Barclays Capital. The stock of CVS Health Corp (NYSE:CVS) has “Neutral” rating given on Thursday, August 17 by Citigroup. The rating was maintained by Mizuho on Thursday, June 23 with “Buy”. The firm earned “Buy” rating on Tuesday, December 13 by Loop Capital.

– Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.

Leave a Reply

Your email address will not be published. Required fields are marked *